HeartSciences Inc. (HSCSW) stock
HSCSWNasdaqFinance ServicesFiscal year ends April 30Also trades as HSCS
$0.07−0.03 (-30.62%)
Close on Oct 30, 2026Market cap $15.89MP/E –Yield 0.00%
HeartSciences net income
Net income is the profit left for shareholders after every expense, interest and tax.
HeartSciences's net income for the twelve months ending Jul 31, 2026 was -$10.26M. For fiscal 2026 it was -$9.14M. The highest annual figure on record is -$4.83M in fiscal 2022.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Apr 30, 2026 | -$9.14M | – |
| FY2025 | Apr 30, 2025 | -$8.77M | – |
| FY2024 | Apr 30, 2024 | -$6.61M | – |
| FY2023 | Apr 30, 2023 | -$6.35M | – |
| FY2022 | Apr 30, 2022 | -$4.83M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027 | Jul 31, 2026 | -$3.17M | – |
| Q4 FY2026 | Apr 30, 2026 | -$2.75M | – |
| Q3 FY2026 | Jan 31, 2026 | -$1.99M | – |
| Q2 FY2026 | Oct 31, 2025 | -$2.35M | – |
| Q1 FY2026 | Jul 31, 2025 | -$2.05M | – |
| Q4 FY2025 | Apr 30, 2025 | -$2.09M | – |
| Q3 FY2025 | Jan 31, 2025 | -$2.54M | – |
| Q2 FY2025 | Oct 31, 2024 | -$2.08M | – |
| Q1 FY2025 | Jul 31, 2024 | -$2.05M | – |
| Q4 FY2024 | Apr 30, 2024 | -$1.85M | – |
| Q3 FY2024 | Jan 31, 2024 | -$1.64M | – |
| Q2 FY2024 | Oct 31, 2023 | -$1.75M | – |
| Q1 FY2024 | Jul 31, 2023 | -$1.37M | – |
| Q4 FY2023 | Apr 30, 2023 | -$1.63M | – |
| Q3 FY2023 | Jan 31, 2023 | -$1.34M | – |
| Q2 FY2023 | Oct 31, 2022 | -$1.81M | – |
| Q1 FY2023 | Jul 31, 2022 | -$1.57M | – |
| Q4 FY2022 | Apr 30, 2022 | -$2.05M | – |
| Q3 FY2022 | Jan 31, 2022 | -$1.24M | – |
| Q2 FY2022 | Oct 31, 2021 | -$1.03M | – |
| Q1 FY2022 | Jul 31, 2021 | -$501.85K | – |